Enveric Biosciences, Inc.: Form 10-Q for the period ended Sep 30, 2015
Filed with the SEC on Nov 23, 2015 and accepted by EDGAR at Nov 23, 2015, 15:58 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cash and equivalents | At period end2015-09-30 | $5.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2015-09-30 | $14.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2015-09-30 | $21.2m | us-gaap:Assets |
| Current liabilities | At period end2015-09-30 | $14.8m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2015-09-30 | $958.8k | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001079974-15-000809. Last ingested by Listed: Nov 14, 2026, 20:02 ET. Listed shows no prices and gives no investment advice.